Meanwhile, due to its specific genetic background, more than 15% of ovarian carcinoma patients carry germline mutations, and an additional 5–11% of patients carry somatic mutations in either the BRCA1 or BRCA2 gene. This evidence concerns the gene BRCA2 and ovarian carcinoma.